Larvol Delta - IRB231681-Ivosidenib-and-Ruxolitinib-in-Patients-With-Advanced-Myeloproliferative-Neoplasms-MPNs-That-Have-an-IDH1-Gene-Mutation

Tibsovo (ivosidenib) - Servier

Jakafi (ruxolitinib) - Incyte

http://clinicaltrials.gov/ct2/show/NCT06291987

Sep 2, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next